Tau-FG-nucleoporin98 interaction and impaired nucleocytoplasmic transport in Alzheimer's disease

Brief Funct Genomics. 2023 Apr 13;22(2):161-167. doi: 10.1093/bfgp/elac022.

Abstract

An emerging pathophysiology associated with the neurodegenerative Alzheimer's disease (AD) is the impairment of nucleocytoplasmic transport (NCT). The impairment can originate from damage to the nuclear pore complex (NPC) or other factors involved in NCT. The phenylalanine-glycine nucleoporins (FG-Nups) form a crucial component of the NPC, which is central to NCT. Recent discoveries have highlighted that the neuropathological protein tau is involved in direct interactions with the FG-Nups and impairment of the NCT process. Targeting such interactions may lead to the identification of novel interaction inhibitors and offer new therapeutic alternatives for the treatment of AD. This review highlights recent findings associated with impaired NCT in AD and the interaction between tau and the FG-Nups.

Keywords: FG-Nup98; hyperphosphorylated tau; neurodegeneration; nuclear membrane; nuclear pore complex; protein–protein interaction.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus / physiology
  • Alzheimer Disease* / metabolism
  • Glycine / metabolism
  • Humans
  • Nuclear Pore / metabolism
  • Nuclear Pore Complex Proteins / metabolism

Substances

  • Nuclear Pore Complex Proteins
  • Glycine